Literature DB >> 11059658

Magnetic resonance imaging stereotactic target localization for deep brain stimulation in dystonic children.

N Vayssiere1, S Hemm, M Zanca, M C Picot, A Bonafe, L Cif, P Frerebeau, P Coubes.   

Abstract

OBJECT: The actual distortion present in a given series of magnetic resonance (MR) images is difficult to establish. The purpose of this study was to validate an MR imaging-based methodology for stereotactic targeting of the internal globus pallidus during electrode implantation in children in whom general anesthesia had been induced.
METHODS: Twelve children (mean follow up 1 year) suffering from generalized dystonia were treated with deep brain stimulation by using a head frame and MR imaging. To analyze the influence of distortions at every step of the procedure, the geometrical characteristics of the frame were first controlled using the localizer as a phantom. Then pre- and postoperative coordinates of fixed anatomical landmarks and electrode positions, both determined with the head frame in place, were statistically compared. No significant difference was observed between theoretical and measured dimensions of the localizer (Student's t-test, ¿t¿ > 2.2 for 12 patients) in the x, y, and z directions. No significant differences were observed (Wilcoxon paired-sample test) between the following: 1) pre- and postoperative coordinates of the anterior commissure (AC) (deltax = 0.3+/-0.29 mm and deltay = 0.34+/-0.32 mm) and posterior commissure (PC) (deltax = 0.15+/-0.18 mm and deltay = 0.34+/-0.25 mm); 2) pre- and postoperative AC-PC distance (deltaL = 0.33+/-0.22 mm); and 3) preoperative target and final electrode position coordinates (deltax = 0.24+/-0.22 mm; deltay = 0.19+/-0.16 mm).
CONCLUSIONS: In the authors' center, MR imaging distortions did not induce detectable errors during stereotactic surgery in dystonic children. Target localization and electrode implantation could be achieved using MR imaging alone after induction of general anesthesia. The remarkable postoperative improvement in these patients confirmed the accuracy of the procedure (Burke-Marsden-Fahn Dystonia Rating Scale score delta = -83.8%).

Entities:  

Mesh:

Year:  2000        PMID: 11059658     DOI: 10.3171/jns.2000.93.5.0784

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Interventional loopless antenna at 7 T.

Authors:  Mehmet Arcan Ertürk; Abdel-Monem M El-Sharkawy; Paul A Bottomley
Journal:  Magn Reson Med       Date:  2011-12-12       Impact factor: 4.668

Review 2.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

3.  Automated segmentation of basal ganglia and deep brain structures in MRI of Parkinson's disease.

Authors:  Claire Haegelen; Pierrick Coupé; Vladimir Fonov; Nicolas Guizard; Pierre Jannin; Xavier Morandi; D Louis Collins
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-03-18       Impact factor: 2.924

Review 4.  Treatment of dystonia with deep brain stimulation.

Authors:  Jill L Ostrem; Philip A Starr
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  Stereotactic model of the electrical distribution within the internal globus pallidus during deep brain stimulation.

Authors:  Xavier Vasques; Laura Cif; Olivier Hess; Sophie Gavarini; Gerard Mennessier; Philippe Coubes
Journal:  J Comput Neurosci       Date:  2008-06-17       Impact factor: 1.621

6.  Deep Brain Stimulation and Hypoxemic Perinatal Encephalopathy: State of Art and Perspectives.

Authors:  Gaëtan Poulen; Emilie Chan-Seng; Emily Sanrey; Philippe Coubes
Journal:  Life (Basel)       Date:  2021-05-25

Review 7.  Neuroimaging and deep brain stimulation.

Authors:  D Dormont; D Seidenwurm; D Galanaud; P Cornu; J Yelnik; E Bardinet
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.